Literature DB >> 21507892

Manitoba-oculo-tricho-anal (MOTA) syndrome is caused by mutations in FREM1.

Anne M Slavotinek1, Sergio E Baranzini, Denny Schanze, Cassandre Labelle-Dumais, Kieran M Short, Ryan Chao, Mani Yahyavi, Emilia K Bijlsma, Catherine Chu, Stacey Musone, Ashleigh Wheatley, Pui-Yan Kwok, Sandra Marles, Jean-Pierre Fryns, A Murat Maga, Mohamed G Hassan, Douglas B Gould, Lohith Madireddy, Chumei Li, Timothy C Cox, Ian Smyth, Albert E Chudley, Martin Zenker.   

Abstract

BACKGROUND: Manitoba-oculo-tricho-anal (MOTA) syndrome is a rare condition defined by eyelid colobomas, cryptophthalmos and anophthalmia/microphthalmia, an aberrant hairline, a bifid or broad nasal tip, and gastrointestinal anomalies such as omphalocele and anal stenosis. Autosomal recessive inheritance had been assumed because of consanguinity in the Oji-Cre population of Manitoba and reports of affected siblings, but no locus or cytogenetic aberration had previously been described. METHODS AND
RESULTS: This study shows that MOTA syndrome is caused by mutations in FREM1, a gene previously mutated in bifid nose, renal agenesis, and anorectal malformations (BNAR) syndrome. MOTA syndrome and BNAR syndrome can therefore be considered as part of a phenotypic spectrum that is similar to, but distinct from and less severe than, Fraser syndrome. Re-examination of Frem1(bat/bat) mutant mice found new evidence that Frem1 is involved in anal and craniofacial development, with anal prolapse, eyelid colobomas, telecanthus, a shortened snout and reduced philtral height present in the mutant mice, similar to the human phenotype in MOTA syndrome.
CONCLUSIONS: The milder phenotypes associated with FREM1 deficiency in humans (MOTA syndrome and BNAR syndrome) compared to that resulting from FRAS1 and FREM2 loss of function (Fraser syndrome) are also consistent with the less severe phenotypes resulting from Frem1 loss of function in mice. Together, Fraser, BNAR and MOTA syndromes constitute a clinically overlapping group of FRAS-FREM complex diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507892      PMCID: PMC4294942          DOI: 10.1136/jmg.2011.089631

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  23 in total

Review 1.  The genetics of Fraser syndrome and the blebs mouse mutants.

Authors:  Ian Smyth; Peter Scambler
Journal:  Hum Mol Genet       Date:  2005-10-15       Impact factor: 6.150

2.  Fraser syndrome: a clinical study of 59 cases and evaluation of diagnostic criteria.

Authors:  Mieke M van Haelst; Peter J Scambler; Raoul C M Hennekam
Journal:  Am J Med Genet A       Date:  2007-12-15       Impact factor: 2.802

3.  Array comparative genomic hybridization in patients with congenital diaphragmatic hernia: mapping of four CDH-critical regions and sequencing of candidate genes at 15q26.1-15q26.2.

Authors:  Anne M Slavotinek; Ali Moshrefi; Randy Davis; Elizabeth Leeth; G Bradley Schaeffer; González Esteban Burchard; Gary M Shaw; Bristow James; Louis Ptacek; Len A Pennacchio
Journal:  Eur J Hum Genet       Date:  2006-05-31       Impact factor: 4.246

4.  Colitis in mice with a high incidence of rectal prolapse.

Authors:  R D Ediger; R M Kovatch; M M Rabstein
Journal:  Lab Anim Sci       Date:  1974-06

5.  Automated splicing mutation analysis by information theory.

Authors:  Vijay K Nalla; Peter K Rogan
Journal:  Hum Mutat       Date:  2005-04       Impact factor: 4.878

6.  Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects.

Authors:  Daiji Kiyozumi; Nagisa Sugimoto; Kiyotoshi Sekiguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

7.  Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs.

Authors:  Shalini Jadeja; Ian Smyth; Jolanta E Pitera; Martin S Taylor; Mieke van Haelst; Elizabeth Bentley; Lesley McGregor; Jason Hopkins; Georges Chalepakis; Nicole Philip; Antonio Perez Aytes; Fiona M Watt; Susan M Darling; Ian Jackson; Adrian S Woolf; Peter J Scambler
Journal:  Nat Genet       Date:  2005-04-17       Impact factor: 38.330

8.  Manitoba Oculotrichoanal (MOTA) syndrome: report of eight new cases.

Authors:  Chumei Li; Sandra L Marles; Cheryl R Greenberg; Bernard N Chodirker; Jiddeke van de Kamp; Anne Slavotinek; Albert E Chudley
Journal:  Am J Med Genet A       Date:  2007-04-15       Impact factor: 2.802

9.  Information analysis of human splice site mutations.

Authors:  P K Rogan; B M Faux; T D Schneider
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

10.  Head blebs: a new mutation on chromosome 4 of the mouse.

Authors:  D S Varnum; S C Fox
Journal:  J Hered       Date:  1981 Jul-Aug       Impact factor: 2.645

View more
  24 in total

Review 1.  Anorectal malformation: the etiological factors.

Authors:  Chen Wang; Long Li; Wei Cheng
Journal:  Pediatr Surg Int       Date:  2015-04-22       Impact factor: 1.827

2.  A homozygous mutation p.Arg2167Trp in FREM2 causes isolated cryptophthalmos.

Authors:  Qian Yu; Bingying Lin; Shangqian Xie; Song Gao; Wei Li; Yizhi Liu; Hongwei Wang; Danping Huang; Zhi Xie
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

3.  fras1 shapes endodermal pouch 1 and stabilizes zebrafish pharyngeal skeletal development.

Authors:  Jared Coffin Talbot; Macie B Walker; Thomas J Carney; Tyler R Huycke; Yi-Lin Yan; Ruth A BreMiller; Linda Gai; April Delaurier; John H Postlethwait; Matthias Hammerschmidt; Charles B Kimmel
Journal:  Development       Date:  2012-08       Impact factor: 6.868

4.  Deficiency of FRAS1-related extracellular matrix 1 (FREM1) causes congenital diaphragmatic hernia in humans and mice.

Authors:  Tyler F Beck; Danielle Veenma; Oleg A Shchelochkov; Zhiyin Yu; Bum Jun Kim; Hitisha P Zaveri; Yolande van Bever; Sunju Choi; Hannie Douben; Terry K Bertin; Pragna I Patel; Brendan Lee; Dick Tibboel; Annelies de Klein; David W Stockton; Monica J Justice; Daryl A Scott
Journal:  Hum Mol Genet       Date:  2012-12-05       Impact factor: 6.150

5.  AMACO is a component of the basement membrane-associated Fraser complex.

Authors:  Rebecca J Richardson; Jan M Gebauer; Jin-Li Zhang; Birgit Kobbe; Douglas R Keene; Kristina Røkenes Karlsen; Stefânia Richetti; Alexander P Wohl; Gerhard Sengle; Wolfram F Neiss; Mats Paulsson; Matthias Hammerschmidt; Raimund Wagener
Journal:  J Invest Dermatol       Date:  2013-11-14       Impact factor: 8.551

6.  Novel FREM1 mutations expand the phenotypic spectrum associated with Manitoba-oculo-tricho-anal (MOTA) syndrome and bifid nose renal agenesis anorectal malformations (BNAR) syndrome.

Authors:  Jared Nathanson; Daniel T Swarr; Amihood Singer; Mochi Liu; Amy Chinn; Wendy Jones; Jane Hurst; Nahla Khalek; Elaine Zackai; Anne Slavotinek
Journal:  Am J Med Genet A       Date:  2013-02-08       Impact factor: 2.802

Review 7.  Novel Insights into the Pathogenesis of Monogenic Congenital Anomalies of the Kidney and Urinary Tract.

Authors:  Amelie T van der Ven; Asaf Vivante; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2017-10-27       Impact factor: 10.121

8.  MOTA Syndrome: Molecular Genetic Confirmation of the Diagnosis in a Newborn with Previously Unreported Clinical Features.

Authors:  D Mitter; D Schanze; I Sterker; D Müller; H Till; M Zenker
Journal:  Mol Syndromol       Date:  2012-07-25

9.  Mild recessive mutations in six Fraser syndrome-related genes cause isolated congenital anomalies of the kidney and urinary tract.

Authors:  Stefan Kohl; Daw-Yang Hwang; Gabriel C Dworschak; Alina C Hilger; Pawaree Saisawat; Asaf Vivante; Natasa Stajic; Radovan Bogdanovic; Heiko M Reutter; Elijah O Kehinde; Velibor Tasic; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

10.  A wedge-shaped anterior hairline extension associated with a tessier number 10 cleft.

Authors:  Hyung Min Lee; Tae Kyung Noh; Han Wook Yoo; Sung Bum Kim; Chong Hyun Won; Sung Eun Chang; Mi Woo Lee; Jee Ho Choi; Kee Chan Moon
Journal:  Ann Dermatol       Date:  2012-11-08       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.